Cellebrite DI Ltd. (NASDAQ: CLBT) reported Q2 EPS of $0.00, $0.02 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $62.6 million versus the consensus estimate of $69.14 million.

For earnings history and earnings-related data on Cellebrite DI Ltd. (CLBT) click here.